February 26, - March 1, 2015
Fontainebleau Miami Beach
4441 Collins Avenue
Miami Beach, FL 33140

The optimal care of patients with breast cancer is rapidly changing as a result of advances in all aspects of patient care, including prevention, screening, and detection, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, and novel biologic therapies. There is an increasing focus on providing multidisciplinary care for patients with complex diseases such as breast cancer through the use of integrated teams of professionals representing the relevant treatment modalities, including surgery, radiation therapy, and systemic medical interventions. The multidisciplinary Miami Breast Cancer Conference^® has been bringing together surgical, medical, and radiation oncologists for 32 years, with the aim of fostering awareness of the state-of-the-art treatments in each therapeutic area and encouraging crossteam cooperation in the clinic. At the 32nd Annual Miami Breast Cancer Conference^®, pioneers of innovative approaches in each of these subspecialties will provide insight into the optimal multidisciplinary management of patients with breast cancer and its application to practice.

This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.

This activity is supported by educational grants from Celgene Corporation, EISAI Corporation, Genentech, Novartis Pharmaceuticals Corporation, Pacira Pharmaceuticals, Inc., and TESARO.

Physicians' Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource^®, LLC designates this live activity for a maximum of 30.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The 32nd Annual Miami Breast Cancer Conference^® Mini-Symposium offers an additional educational opportunity for attendees who plan to arrive in Miami the day before the official conference begins. The Mini-Symposium takes the format of a World-Class Tumor Board, featuring cases and discussions that highlight challenging clinical situations commonly faced by surgeons and oncologists, including:

• The value of excision when LCIS is found at core needle biopsy
• Breast-conservation therapy by tumor biologic subtype
• The challenge of pain management
• Defining and managing invasive lobular carcinoma
• Regional node irradiation in sentinel node–positive disease
• Contemporary issues in lymphedema
• Therapy for intermediate-risk ER-positive, HER2-negative tumors
• And more…

This special session was developed to be of interest to healthcare practitioners from all specialties, and will provide practical information to enhance patient care in the clinic, delivered by top experts in the field of breast cancer. If your schedule allows, we hope you will plan to attend and take advantage of this extra session!

Note: Separate registration is required.

Patrick I. Borgen, MD
Chair, Department of Surgery
Maimonides Medical Center
Brooklyn, NY